Announcements & Press Releases

DENVER, Colo., April 23, 2012 – Accelr8 Technology Corporation (Amex: AXK) announced today that an investment group formed by Jack Schuler, John Patience, and Larry Mehren will invest a total of...

Accelr8 Announces New ManagementDenver, Co., June 26, 2012 – Accelr8 Technology Corporation (NYSE MKT: AXK) today announced the appointment of Lawrence Mehren as President and Chief Executive...

Accelr8 Announces Development Expansion for Blood-Based Diagnostic TestsDENVER, Colo., November 22, 2011 – Accelr8 Technology Corporation (NYSE Amex: AXK) announced that it successfully completed...

Accelr8 Announces Interim Plan and Advanced StudiesDENVER, Colo., October 13, 2011 – Accelr8 Technology Corporation (NYSE Amex: AXK) announced that upon reaching the end of its technology...

Accelr8 Announces Renewal and Expansion of SCHOTT Microarray License, and Notice of Allowance for New PatentDENVER, Colo., September 22, 2011 – Accelr8 Technology Corporation (NYSE Amex: AXK)...

Accelr8 Announces Results in Award-Winning Presentation for Rapid Diagnostics with ICU SpecimensCHIGACO, Ill., September 19, 2011 – Accelr8 Technology Corporation (NYSE Amex: AXK) announced...

Accelr8 Announces Continuation and Expansion of BACcel™ Development Collaboration DENVER, Colo., July 25, 2011 – Accelr8 Technology Corporation (NYSE Amex: AXK) announced that Accelr8 and...

Accelr8 to Receive Award for ICAAC PresentationThe presentation title is "Same-Shift ID Directly from Respiratory Specimens by Automated Microscopy." It will report results from a study using Accelr8'

Accelr8 Announces Continuation of BACcel™ CollaborationDENVER, Colo., June 30, 2011 – Accelr8 Technology Corporation (NYSE Amex: AXK) announced that the company agreed to extend its letter of...

Accelr8 4-Hour Test Identifies New Drug-Resistant "Staph" (hVISA) Undetectable by Hospital LabsDENVER, Colo., May 23, 2011 – Accelr8 Technology Corporation (NYSE Amex: AXK) announced results from...